 <h1>Emend for Injection Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>fosaprepitant</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about fosaprepitant. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Emend for Injection.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to fosaprepitant: intravenous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, fosaprepitant (the active ingredient contained in Emend for Injection) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking fosaprepitant:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>blurred vision</li>
<li>chills</li>
<li>confusion</li>
<li>cough</li>
<li>decreased urination</li>
<li>difficult or labored breathing</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>fainting</li>
<li>fever</li>
<li>increase in heart rate</li>
<li>lightheadedness</li>
<li>lower back or side pain</li>
<li>nervousness</li>
<li>pain, swelling, or redness at the injection site</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pounding in the ears</li>
<li>rapid breathing</li>
<li>slow or fast heartbeat</li>
<li>sore throat</li>
<li>sunken eyes</li>
<li>tenderness, swelling, warmth, or skin discoloration at the injection site</li>
<li>thirst</li>
<li>tightness in the chest</li>
<li>ulcers, sores, or white spots in the mouth</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>wrinkled skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Hard lump at the injection site</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blood in the urine</li>
<li>changes in patterns and rhythms of speech</li>
<li>changes in skin color</li>
<li>chest pain or discomfort</li>
<li>fast, slow, irregular, pounding, or racing heartbeat or pulse</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>increased sweating</li>
<li>increased thirst</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>loss of consciousness</li>
<li>muscle pain or cramps</li>
<li>nausea</li>
<li>pain, tenderness, or swelling of the foot or leg</li>
<li>seizures</li>
<li>slurred speech</li>
<li>swelling</li>
<li>swelling of the face, ankles, or hands</li>
<li>trouble with speaking</li>
<li>troubled breathing with exertion</li>
<li>vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Diarrhea</li>
<li>difficulty with swallowing</li>
<li>hives or welts, itching</li>
<li>joint pain</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>redness of the skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of fosaprepitant may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Belching</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>continuing ringing or buzzing or other unexplained noise in ears</li>
<li>difficulty having a bowel movement</li>
<li>dizziness</li>
<li>feeling of indigestion</li>
<li>hair loss or thinning of the hair</li>
<li>hearing loss</li>
<li>hiccups</li>
<li>indigestion</li>
<li>lack or loss of strength</li>
<li>loss of appetite</li>
<li>pain in the chest below the breastbone</li>
<li>stomach discomfort, upset, or pain</li>
<li>swelling or inflammation of the mouth</li>
<li>weight loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Feeling of warmth</li>
<li>pain or discomfort in chest, upper stomach, or throat</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>sudden sweating</li>
<li>unusually warm skin</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Abnormal dreams</li>
<li>blemishes on the skin</li>
<li>bumps on the skin</li>
<li>burning, dry, or itching eyes</li>
<li>change in taste</li>
<li>change in walking and balance</li>
<li>clumsiness or unsteadiness</li>
<li>confusion about identity, place, and time</li>
<li>difficulty with moving</li>
<li>discharge, excessive tearing</li>
<li>excess air or gas in the stomach</li>
<li>extreme thirst</li>
<li>false or unusual sense of well-being</li>
<li>flushed, dry skin</li>
<li>frequent urination</li>
<li>fruit-like breath odor</li>
<li>full feeling</li>
<li>heartburn</li>
<li>increased hunger</li>
<li>increased sensitivity of the skin to sunlight</li>
<li>increased urination</li>
<li>increased volume of pale, dilute urine</li>
<li>muscle ache, cramp, stiffness, or weakness</li>
<li>oily skin</li>
<li>passing gas</li>
<li>pimples</li>
<li>redness or other discoloration of the skin</li>
<li>redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>severe constipation</li>
<li>severe sunburn</li>
<li>sleepiness</li>
<li>stomach distension</li>
<li>sweating</li>
<li>swollen joints</li>
<li>trouble performing routine tasks</li>
<li>trouble sleeping</li>
<li>unexplained weight loss</li>
<li>unusual drowsiness, dullness, or feeling of sluggishness</li>
<li>weight gain</li>
<li>white patches with diaper rash</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to fosaprepitant: intravenous powder for injection</i></p><h3>General</h3><p>The most common side effects include fatigue and diarrhea.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Asthenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Malaise</p>
<p><b>Rare</b> (0.01% to 0.1%): Tinnitus<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Constipation and subileus occurred at higher doses.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Diarrhea (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Constipation, dyspepsia</p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal distention, abdominal pain, abdominal pain upper, dry mouth, eructation, flatulence, gastroesophageal reflux disease, nausea, oral candidiasis, vomiting</p>
<p><b>Rare</b> (0.01% to 0.1%): Duodenal ulcer perforation, hard feces, neutropenic colitis, stomatitis</p>
<p><b>Frequency not reported</b>: Bowel sounds abnormal, stomach discomfort, subileus<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, leukopenia, neutropenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Febrile neutropenia</p>
<p><b>Rare</b> (0.01% to 0.1%): Neutrophil count decreased<sup>[Ref]</sup></p><h3>Local</h3><p>Infusion site reactions occurred in 2.2% of patients, compared to 0.6% given ondansetron and dexamethasone (standard therapy).  These reactions included infusion site pain, injection site irritation, vessel-puncture site pain, and infusion site thrombophlebitis.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Infusion-site pain, infusion site reactions</p>
<p><b>Uncommon</b> (0.1% to 1%): Infusion site erythema, infusion site induration, infusion site pruritus, infusion site thrombophlebitis, injection site irritation, vessel puncture-site pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, peripheral neuropathy</p>
<p><b>Uncommon</b> (0.1% to 1%): Dizziness, somnolence</p>
<p><b>Rare</b> (0.01% to 0.1%): Cognitive disorder, dysgeusia, gait disturbance, lethargy</p>
<p><b>Frequency not reported</b>: Dysarthria, hypoesthesia, sensory disturbance, syncope</p>
<p><b>Postmarketing reports</b>: Ifosfamide-induced neurotoxicity<sup>[Ref]</sup></p><p>Ifosfamide-induced neurotoxicity occurred after coadministration with ifosfamide.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Hiccups</p>
<p><b>Uncommon</b> (0.1% to 1%): Cough, oropharyngeal pain, throat irritation</p>
<p><b>Rare</b> (0.01% to 0.1%): Postnasal drip, sneezing</p>
<p><b>Frequency not reported</b>: Dyspnea, wheezing</p>
<p><b>Postmarketing reports</b>: Chest tightness<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Dysuria</p>
<p><b>Rare</b> (0.01% to 0.1%): Glucose urine present, pollakiuria, red blood cells urine positive, urine output increased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p>
<p><b>Uncommon</b> (0.1% to 1%): Blood alkaline phosphatase increased</p>
<p><b>Rare</b> (0.01% to 0.1%): Blood sodium decreased, polydipsia, weight decrease<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increased, AST increased</p>
<p><b>Frequency not reported</b>: Blood bilirubin increased<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Pain in extremity</p>
<p>Rare (0.01% to 0.1%) Muscular weakness, muscle spasms<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Blood pressure increased, flushing, hot flush, palpitations, thrombophlebitis</p>
<p><b>Rare</b> (0.01% to 0.1%): Bradycardia, cardiovascular disorder, chest discomfort, edema</p>
<p><b>Frequency not reported</b>: Hypotension<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Acne, erythema, rash</p>
<p><b>Rare</b> (0.01% to 0.1%): Hyperhidrosis, photosensitivity reaction, rash pruritic, seborrhea, skin lesion, Stevens-Johnson syndrome, toxic epidermal necrolysis</p>
<p><b>Frequency not reported</b>: Pruritus, urticaria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Anxiety</p>
<p><b>Rare</b> (0.01% to 0.1%): Disorientation, euphoric mood</p>
<p><b>Frequency not reported</b>: Insomnia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (0.01% to 0.1%): Candidiasis, staphylococcal infection<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (0.01% to 0.1%): Conjunctivitis</p>
<p><b>Frequency not reported</b>: Miosis, visual acuity reduced<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactic reactions, anaphylactic shock, angioedema, hypersensitivity reactions, immediate hypersensitivity reactions<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Emend for Injection (fosaprepitant)." Merck &amp; Company Inc, West Point, PA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What is the difference between Cinvanti and Emend?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Emend for Injection (fosaprepitant)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: NK1 receptor antagonists</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Emend</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Nausea/Vomiting, Chemotherapy Induced</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to fosaprepitant: intravenous powder for injection</i></p><h3>General</h3><p>The most common side effects include fatigue and diarrhea.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (up to 15%)</p><p><b>Common</b> (1% to 10%): Asthenia</p><p><b>Uncommon</b> (0.1% to 1%): Malaise</p><p><b>Rare</b> (0.01% to 0.1%): Tinnitus<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Constipation and subileus occurred at higher doses.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Diarrhea (up to 13%)</p><p><b>Common</b> (1% to 10%): Constipation, dyspepsia</p><p><b>Uncommon</b> (0.1% to 1%): Abdominal distention, abdominal pain, abdominal pain upper, dry mouth, eructation, flatulence, gastroesophageal reflux disease, nausea, oral candidiasis, vomiting</p><p><b>Rare</b> (0.01% to 0.1%): Duodenal ulcer perforation, hard feces, neutropenic colitis, stomatitis</p><p><b>Frequency not reported</b>: Bowel sounds abnormal, stomach discomfort, subileus<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, leukopenia, neutropenia</p><p><b>Uncommon</b> (0.1% to 1%): Febrile neutropenia</p><p><b>Rare</b> (0.01% to 0.1%): Neutrophil count decreased<sup>[Ref]</sup></p><h3>Local</h3><p>Infusion site reactions occurred in 2.2% of patients, compared to 0.6% given ondansetron and dexamethasone (standard therapy).  These reactions included infusion site pain, injection site irritation, vessel-puncture site pain, and infusion site thrombophlebitis.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Infusion-site pain, infusion site reactions</p><p><b>Uncommon</b> (0.1% to 1%): Infusion site erythema, infusion site induration, infusion site pruritus, infusion site thrombophlebitis, injection site irritation, vessel puncture-site pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, peripheral neuropathy</p><p><b>Uncommon</b> (0.1% to 1%): Dizziness, somnolence</p><p><b>Rare</b> (0.01% to 0.1%): Cognitive disorder, dysgeusia, gait disturbance, lethargy</p><p><b>Frequency not reported</b>: Dysarthria, hypoesthesia, sensory disturbance, syncope</p><p><b>Postmarketing reports</b>: Ifosfamide-induced neurotoxicity<sup>[Ref]</sup></p><p>Ifosfamide-induced neurotoxicity occurred after coadministration with ifosfamide.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Hiccups</p><p><b>Uncommon</b> (0.1% to 1%): Cough, oropharyngeal pain, throat irritation</p><p><b>Rare</b> (0.01% to 0.1%): Postnasal drip, sneezing</p><p><b>Frequency not reported</b>: Dyspnea, wheezing</p><p><b>Postmarketing reports</b>: Chest tightness<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Dysuria</p><p><b>Rare</b> (0.01% to 0.1%): Glucose urine present, pollakiuria, red blood cells urine positive, urine output increased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p><p><b>Uncommon</b> (0.1% to 1%): Blood alkaline phosphatase increased</p><p><b>Rare</b> (0.01% to 0.1%): Blood sodium decreased, polydipsia, weight decrease<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increased, AST increased</p><p><b>Frequency not reported</b>: Blood bilirubin increased<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Pain in extremity</p><p>Rare (0.01% to 0.1%) Muscular weakness, muscle spasms<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Blood pressure increased, flushing, hot flush, palpitations, thrombophlebitis</p><p><b>Rare</b> (0.01% to 0.1%): Bradycardia, cardiovascular disorder, chest discomfort, edema</p><p><b>Frequency not reported</b>: Hypotension<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Acne, erythema, rash</p><p><b>Rare</b> (0.01% to 0.1%): Hyperhidrosis, photosensitivity reaction, rash pruritic, seborrhea, skin lesion, Stevens-Johnson syndrome, toxic epidermal necrolysis</p><p><b>Frequency not reported</b>: Pruritus, urticaria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Anxiety</p><p><b>Rare</b> (0.01% to 0.1%): Disorientation, euphoric mood</p><p><b>Frequency not reported</b>: Insomnia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (0.01% to 0.1%): Candidiasis, staphylococcal infection<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (0.01% to 0.1%): Conjunctivitis</p><p><b>Frequency not reported</b>: Miosis, visual acuity reduced<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactic reactions, anaphylactic shock, angioedema, hypersensitivity reactions, immediate hypersensitivity reactions<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Emend for Injection (fosaprepitant)." Merck &amp; Company Inc, West Point, PA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is the difference between Cinvanti and Emend?</li>
</ul><h2>More about Emend for Injection (fosaprepitant)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: NK1 receptor antagonists</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Emend</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Nausea/Vomiting, Chemotherapy Induced</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>